Literature DB >> 3035010

Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.

J M Sheil, M J Bevan, L Lefrancois.   

Abstract

Cross-reactive recognition of alloantigen by "self + X"-reactive cytotoxic T lymphocytes (CTL) has been documented in a variety of systems. It has been shown previously that the H-2Kb-restricted CTL response of C57BL/6 (B6) mice to vesicular stomatitis virus (VSV) infection is partially cross-reactive on uninfected target cells expressing the H-2Kbm8 mutation. In this report, we describe the isolation and detailed characterization of such dual-reactive CTL. By employing EL4 tumor lines transfected with genes encoding various VSV proteins, we demonstrated that the majority of dual-reactive CTL recognize the internal N protein of VSV and are also reactive against uninfected bm8 targets. Although the response of normal B6 mice to bm8 stimulators shows no measurable cross-reactivity on VSV-infected targets, the response of VSV-primed B6 mice to bm8 stimulation is almost entirely cross-reactive, lysing VSV-B6 targets and uninfected bm8 targets roughly equally. Furthermore, about 70% of CTL clones isolated from such mice by bm8 stimulation are dual-reactive with respect to effector function. Analysis at the population and clonal levels with cold target competition and antibody blocking suggests that the bulk of dual-reactive CTL have a higher avidity for VSV-B6 targets than for bm8 targets. The extreme case of this is illustrated by a fraction of CTL clones, isolated and maintained on bm8 stimulators, which lyse VSV-B6 targets but do not lyse bm8 targets. One such CTL clone is shown to be specific for the bm8 antigen in proliferation assays. These results demonstrate that: the specificity of an alloreactive CTL response may be dramatically altered by previous antigenic encounters; and dual-reactive CTL display a significant difference in affinity of the CTL receptor-determinant interaction, depending on the target which is recognized.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035010

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro.

Authors:  C J Kim; T Prevette; J Cormier; W Overwijk; M Roden; N P Restifo; S A Rosenberg; F M Marincola
Journal:  J Immunother       Date:  1997-07       Impact factor: 4.456

2.  Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.

Authors:  Sandra Reichstetter; Nathan E Standifer; Kelly A Geubtner; Andrew W Liu; Stacy L Agar; William W Kwok
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 3.  Recent progress and new perspectives in studying T cell responses to allografts.

Authors:  A Valujskikh; W M Baldwin; R L Fairchild
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

4.  A single antigen-specific B cell can conjugate to either a type 1 or a type 2 helper T cell.

Authors:  V M Sanders; R Fernandez-Botran; R L Coffman; T R Mosmann; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.

Authors:  E S Song; R Linsk; C A Olson; M McMillan; R S Goodenow
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity.

Authors:  M A Brehm; K A Daniels; B Priyadharshini; T B Thornley; D L Greiner; A A Rossini; R M Welsh
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

7.  Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.

Authors:  R M Welsh; T G Markees; B A Woda; K A Daniels; M A Brehm; J P Mordes; D L Greiner; A A Rossini
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.

Authors:  D M Roscoe; K Ishikawa; D S Lyles
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.

Authors:  J Gopas; D Itzhaky; Y Segev; S Salzberg; B Trink; N Isakov; B Rager-Zisman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.